Login to Your Account



Despite reforms, China's pharma industry lagging in key areas

By Carmen Ho
Staff Writer

Wednesday, July 12, 2017

GUANGZHOU, China – China's health care reforms have made great strides toward developing the country's pharmaceutical industry, but the current ecosystem may not be enough for China to compete on the world stage of drug development, said industry experts and regulators at this week's GF Securities Life Sciences Investment Conference.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription